Chapter/Section Purchase

1 Study Coverage
1.1 Swine Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Swine Influenza Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Swine Influenza Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Commodity Pig
1.3.3 Breeding Pig
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Swine Influenza Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Swine Influenza Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Swine Influenza Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Swine Influenza Vaccines Sales by Region
2.4.1 Global Swine Influenza Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Swine Influenza Vaccines by Region (2023-2028)
2.5 Global Swine Influenza Vaccines Revenue by Region
2.5.1 Global Swine Influenza Vaccines Revenue by Region (2017-2022)
2.5.2 Global Swine Influenza Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Swine Influenza Vaccines Sales by Manufacturers
3.1.1 Global Top Swine Influenza Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Swine Influenza Vaccines in 2021
3.2 Global Swine Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Swine Influenza Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Swine Influenza Vaccines Revenue in 2021
3.3 Global Swine Influenza Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Swine Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Swine Influenza Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Swine Influenza Vaccines Sales by Type
4.1.1 Global Swine Influenza Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Swine Influenza Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Swine Influenza Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Swine Influenza Vaccines Revenue by Type
4.2.1 Global Swine Influenza Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Swine Influenza Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Swine Influenza Vaccines Price by Type
4.3.1 Global Swine Influenza Vaccines Price by Type (2017-2022)
4.3.2 Global Swine Influenza Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Swine Influenza Vaccines Sales by Application
5.1.1 Global Swine Influenza Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Swine Influenza Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Swine Influenza Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Swine Influenza Vaccines Revenue by Application
5.2.1 Global Swine Influenza Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Swine Influenza Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Swine Influenza Vaccines Price by Application
5.3.1 Global Swine Influenza Vaccines Price by Application (2017-2022)
5.3.2 Global Swine Influenza Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Swine Influenza Vaccines Market Size by Type
6.1.1 North America Swine Influenza Vaccines Sales by Type (2017-2028)
6.1.2 North America Swine Influenza Vaccines Revenue by Type (2017-2028)
6.2 North America Swine Influenza Vaccines Market Size by Application
6.2.1 North America Swine Influenza Vaccines Sales by Application (2017-2028)
6.2.2 North America Swine Influenza Vaccines Revenue by Application (2017-2028)
6.3 North America Swine Influenza Vaccines Market Size by Country
6.3.1 North America Swine Influenza Vaccines Sales by Country (2017-2028)
6.3.2 North America Swine Influenza Vaccines Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Swine Influenza Vaccines Market Size by Type
7.1.1 Europe Swine Influenza Vaccines Sales by Type (2017-2028)
7.1.2 Europe Swine Influenza Vaccines Revenue by Type (2017-2028)
7.2 Europe Swine Influenza Vaccines Market Size by Application
7.2.1 Europe Swine Influenza Vaccines Sales by Application (2017-2028)
7.2.2 Europe Swine Influenza Vaccines Revenue by Application (2017-2028)
7.3 Europe Swine Influenza Vaccines Market Size by Country
7.3.1 Europe Swine Influenza Vaccines Sales by Country (2017-2028)
7.3.2 Europe Swine Influenza Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Swine Influenza Vaccines Market Size by Type
8.1.1 Asia Pacific Swine Influenza Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Swine Influenza Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Swine Influenza Vaccines Market Size by Application
8.2.1 Asia Pacific Swine Influenza Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Swine Influenza Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Swine Influenza Vaccines Market Size by Region
8.3.1 Asia Pacific Swine Influenza Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Swine Influenza Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Swine Influenza Vaccines Market Size by Type
9.1.1 Latin America Swine Influenza Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Swine Influenza Vaccines Revenue by Type (2017-2028)
9.2 Latin America Swine Influenza Vaccines Market Size by Application
9.2.1 Latin America Swine Influenza Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Swine Influenza Vaccines Revenue by Application (2017-2028)
9.3 Latin America Swine Influenza Vaccines Market Size by Country
9.3.1 Latin America Swine Influenza Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Swine Influenza Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Swine Influenza Vaccines Market Size by Type
10.1.1 Middle East and Africa Swine Influenza Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Swine Influenza Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Swine Influenza Vaccines Market Size by Application
10.2.1 Middle East and Africa Swine Influenza Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Swine Influenza Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Swine Influenza Vaccines Market Size by Country
10.3.1 Middle East and Africa Swine Influenza Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Swine Influenza Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Chengdu TECBOND
11.1.1 Chengdu TECBOND Corporation Information
11.1.2 Chengdu TECBOND Overview
11.1.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Chengdu TECBOND Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chengdu TECBOND Recent Developments
11.2 Green Cross Veterinary
11.2.1 Green Cross Veterinary Corporation Information
11.2.2 Green Cross Veterinary Overview
11.2.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Green Cross Veterinary Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Green Cross Veterinary Recent Developments
11.3 Hipra
11.3.1 Hipra Corporation Information
11.3.2 Hipra Overview
11.3.3 Hipra Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Hipra Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hipra Recent Developments
11.4 MSD Animal Health (Merck)
11.4.1 MSD Animal Health (Merck) Corporation Information
11.4.2 MSD Animal Health (Merck) Overview
11.4.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 MSD Animal Health (Merck) Recent Developments
11.5 Zoetis
11.5.1 Zoetis Corporation Information
11.5.2 Zoetis Overview
11.5.3 Zoetis Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zoetis Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zoetis Recent Developments
11.6 CAHIC
11.6.1 CAHIC Corporation Information
11.6.2 CAHIC Overview
11.6.3 CAHIC Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CAHIC Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CAHIC Recent Developments
11.7 Merial
11.7.1 Merial Corporation Information
11.7.2 Merial Overview
11.7.3 Merial Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Merial Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merial Recent Developments
11.8 Ceva
11.8.1 Ceva Corporation Information
11.8.2 Ceva Overview
11.8.3 Ceva Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Ceva Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ceva Recent Developments
11.9 Ringpu Biology
11.9.1 Ringpu Biology Corporation Information
11.9.2 Ringpu Biology Overview
11.9.3 Ringpu Biology Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ringpu Biology Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ringpu Biology Recent Developments
11.10 DHN
11.10.1 DHN Corporation Information
11.10.2 DHN Overview
11.10.3 DHN Swine Influenza Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 DHN Swine Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 DHN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Swine Influenza Vaccines Industry Chain Analysis
12.2 Swine Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Swine Influenza Vaccines Production Mode & Process
12.4 Swine Influenza Vaccines Sales and Marketing
12.4.1 Swine Influenza Vaccines Sales Channels
12.4.2 Swine Influenza Vaccines Distributors
12.5 Swine Influenza Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Swine Influenza Vaccines Industry Trends
13.2 Swine Influenza Vaccines Market Drivers
13.3 Swine Influenza Vaccines Market Challenges
13.4 Swine Influenza Vaccines Market Restraints
14 Key Findings in The Global Swine Influenza Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer